Fusion Pharmaceuticals Inc (NASDAQ:FUSN) major shareholder Johnson & Johnson purchased 725,000 shares of the firm’s stock in a transaction on Tuesday, June 30th. The stock was acquired at an average price of $17.00 per share, with a total value of $12,325,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
NASDAQ FUSN traded up $1.10 on Monday, hitting $17.10. The company’s stock had a trading volume of 487,300 shares.
About Fusion Pharmaceuticals
Featured Article: What does a market perform rating mean?
Receive News & Ratings for Fusion Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fusion Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.